association

Full identifier: http://purl.org/np/RAuYDKSYRolP70ZO_uCozjBH1K2vU--AVofYQc7d9LLWg#association

Assigned to 1 class:

Minted in Nanopublication

 RAuYDKSYRo comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAuYDKSYRo... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-14T08:22:21.307+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAuYDKSYRo... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAuYDKSYRo... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAuYDKSYRo... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
dalfampridine extended release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis ms this was demonstrated by an increase in walking speed see clinical studies 14 dalfampridine extended release tablets are a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis ms this was demonstrated by an increase in walking speed 1 14
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-14T06:22:21.307Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)